Patient Characteristics and Public Health Office Factors Associated With Long Reporting Delay of COVID-19 Cases in Sapporo City, Japan
Background: For therapeutic efficacy, molnupiravir and nirmatrelvir-ritonavir must be started to treat patients within 5 days of disease onset to treat patients with novel coronavirus disease 2019 (COVID-19). However, some patients spend more than 5 days from disease onset before reporting to the Pu...
Saved in:
Published in | Journal of Epidemiology Vol. 34; no. 3; pp. 129 - 136 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
Japan Epidemiological Association
05.03.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!